Correlation between the low marrow blast cutpoint and WHO classification for myelodysplastic syndromes

被引：1
|
作者：
Matsuda, Akira [1 ]
Germing, Ulrich [2 ]
Miyazaki, Yasushi [3 ]
机构：
[1] Saitama Med Univ, Saitama Int Med Ctr, Dept Hematooncol, Hidaka, Saitama 3501298, Japan
[2] Univ Dusseldorf, Dept Hematol Oncol & Clin Immunol, D-40225 Dusseldorf, Germany
[3] Nagasaki Univ, Grad Sch Biomed Sci, Atom Bomb Dis Inst, Dept Hematol,Mol Med Unit, Nagasaki 852, Japan
来源：
EUROPEAN JOURNAL OF HAEMATOLOGY | 2013年 / 90卷 / 01期
关键词：
PROGNOSTIC SCORING SYSTEM;
D O I：
10.1111/ejh.12024
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：79 / 80
页数：2
相关论文
共 50 条
  • [21] Correlation of bone marrow angiogenesis and mast cells with tryptase activity in myelodysplastic syndromes
    Ribatti, D
    Polimeno, G
    Vacca, A
    Marzullo, A
    Crivellato, E
    Nico, B
    Lucarelli, G
    Dammacco, F
    LEUKEMIA, 2002, 16 (09) : 1680 - 1684
  • [22] Correlation of bone marrow angiogenesis and mast cells with tryptase activity in myelodysplastic syndromes
    D Ribatti
    G Polimeno
    A Vacca
    A Marzullo
    E Crivellato
    B Nico
    G Lucarelli
    F Dammacco
    Leukemia, 2002, 16 : 1680 - 1684
  • [23] High PRAME expression is associated with poor survival and early disease progression in myelodysplastic syndromes with a low bone marrow blast percentage
    Shiseki, Masayuki
    Ishii, Mayuko
    Ohwashi, Mari
    Wang, Yan-Hua
    Tanaka, Norina
    Osanai, Satoko
    Yoshinaga, Kentaro
    Mori, Naoki
    Tanaka, Junji
    LEUKEMIA & LYMPHOMA, 2021, 62 (10) : 2448 - 2456
  • [24] CORRELATION BETWEEN BONE-MARROW KARYOTYPE AND THE OCCURRENCE OF ERYTHROBLAST MICRONUCLEI AND NUCLEAR BUDDING IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES
    TEERENHOVI, L
    LINTULA, R
    RUUTU, T
    KNUUTILA, S
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1987, 39 (03) : 237 - 240
  • [25] IS THERE A RELATIONSHIP BETWEEN BONE MARROW CYTOMORPHOLOGY AND FLOW CYTOMETRY IN MYELODYSPLASTIC SYNDROMES?
    Morvan, C.
    Guerin, E.
    Trimoreau, F.
    Gourin, M. P.
    Woillard, J. B.
    Olombel, P.
    Couraud, M. J.
    Bourinet, A.
    Feuillard, J.
    HAEMATOLOGICA, 2014, 99 : 86 - 86
  • [26] The new WHO and ICC classification systems for myelodysplastic syndromes and their impact on the clinical laboratory
    Frido K. Bruehl
    Mazen M. Osman
    Dong Chen
    Joanna C. Dalland
    Journal of Hematopathology, 2023, 16 : 65 - 71
  • [27] Changes in the Updated 2016: WHO Classification of the Myelodysplastic Syndromes and Related Myeloid Neoplasms
    Bennett, John M.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2016, 16 (11): : 607 - 609
  • [28] The new WHO and ICC classification systems for myelodysplastic syndromes and their impact on the clinical laboratory
    Bruehl, Frido K.
    Osman, Mazen M.
    Chen, Dong
    Dalland, Joanna C.
    JOURNAL OF HEMATOPATHOLOGY, 2023, 16 (02) : 65 - 71
  • [29] Myelodysplastic syndromes according to FAB and WHO classification. Single center experience
    Haus, O
    Kotlarek-Haus, S
    Potoczek, S
    Czarnecka, M
    Duszenko, E
    Makowska, I
    Mirowska, N
    Kuliczkowski, K
    NEOPLASMA, 2006, 53 (02) : 136 - 143
  • [30] Prognostic value of bone marrow histology in myelodysplastic syndromes classified according to WHO criteria
    Della Porta, M. G.
    Malcovati, L.
    Boveri, E.
    Travaglino, E.
    Pascutto, C.
    Maffioli, M.
    Invemizzi, R.
    Castello, A.
    Magrini, U.
    Lazzarino, L.
    Cazzola, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 159 - 159
12345